- Home
- KROS vs SLQT Comparison
KROS vs SLQT Comparison
Compare KROS & SLQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- SLQT
- Stock Information
- Founded
- KROS 2015
- SLQT 1999
- Country
- KROS United States
- SLQT United States
- Employees
- KROS N/A
- SLQT N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- SLQT Specialty Insurers
- Sector
- KROS Health Care
- SLQT Finance
- Exchange
- KROS Nasdaq
- SLQT Nasdaq
- Market Cap
- KROS 460.6M
- SLQT 735.8M
- IPO Year
- KROS 2020
- SLQT 2020
- Fundamental
- Price
- KROS $11.13
- SLQT $4.51
- Analyst Decision
- KROS Buy
- SLQT Hold
- Analyst Count
- KROS 11
- SLQT 1
- Target Price
- KROS $45.33
- SLQT $4.00
- AVG Volume (30 Days)
- KROS 2.1M
- SLQT 1.1M
- Earning Date
- KROS 02-26-2025
- SLQT 02-14-2025
- Dividend Yield
- KROS N/A
- SLQT N/A
- EPS Growth
- KROS N/A
- SLQT N/A
- EPS
- KROS N/A
- SLQT N/A
- Revenue
- KROS $651,000.00
- SLQT $1,381,309,000.00
- Revenue This Year
- KROS $303.27
- SLQT $12.73
- Revenue Next Year
- KROS N/A
- SLQT $14.03
- P/E Ratio
- KROS N/A
- SLQT N/A
- Revenue Growth
- KROS 8037.50
- SLQT 28.72
- 52 Week Low
- KROS $9.78
- SLQT $1.08
- 52 Week High
- KROS $73.00
- SLQT $4.64
- Technical
- Relative Strength Index (RSI)
- KROS 25.01
- SLQT 62.24
- Support Level
- KROS $11.04
- SLQT $4.07
- Resistance Level
- KROS $11.36
- SLQT $4.60
- Average True Range (ATR)
- KROS 0.53
- SLQT 0.28
- MACD
- KROS 1.15
- SLQT -0.04
- Stochastic Oscillator
- KROS 37.80
- SLQT 84.09
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.